# Gentian Violet Treatment for Hidradenitis Suppurativa

> **NCT04388163** · PHASE2 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Gentian Violet

## Key facts

- **NCT ID:** NCT04388163
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-08
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drug company did not approve use of the drug, IRB never approved
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04388163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04388163, "Gentian Violet Treatment for Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04388163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*